DNMT1 and thyroid gland carcinoma: Previous evidence has shown that DNMT1 is overexpressed in breast cancer (Wang et al., 2018), thyroid cancer cells (Zhang et al., 2018), and pancreatic cancer (Peng et al., 2005).